Zhixiang Zuo

18.1k total citations · 4 hit papers
113 papers, 6.5k citations indexed

About

Zhixiang Zuo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhixiang Zuo has authored 113 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 41 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Zhixiang Zuo's work include RNA modifications and cancer (40 papers), Cancer-related molecular mechanisms research (25 papers) and Cancer-related gene regulation (14 papers). Zhixiang Zuo is often cited by papers focused on RNA modifications and cancer (40 papers), Cancer-related molecular mechanisms research (25 papers) and Cancer-related gene regulation (14 papers). Zhixiang Zuo collaborates with scholars based in China, United States and Germany. Zhixiang Zuo's co-authors include Xiaolian Gao, Feifei Xiao, Tianhao Li, Guoping Cai, Seok Yun Kang, Jian Ren, Yubin Xie, Qi Zhao, Aiping Mao and Xiaotong Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Zhixiang Zuo

107 papers receiving 6.5k citations

Hit Papers

miRecords: an integrated resource for microRNA-target int... 2008 2026 2014 2020 2008 2015 2019 2015 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixiang Zuo China 36 4.5k 2.5k 803 632 499 113 6.5k
Achim Aigner Germany 51 6.7k 1.5× 2.0k 0.8× 92 0.1× 1.1k 1.7× 520 1.0× 204 9.2k
Zicai Liang China 45 3.8k 0.9× 1.2k 0.5× 114 0.1× 199 0.3× 125 0.3× 125 5.7k
Xiongbin Lu United States 49 4.9k 1.1× 1.9k 0.7× 132 0.2× 2.1k 3.4× 342 0.7× 112 7.5k
Xiaoting Chen China 29 2.9k 0.6× 597 0.2× 65 0.1× 466 0.7× 302 0.6× 116 4.7k
Younghoon Lee South Korea 38 3.3k 0.7× 451 0.2× 280 0.3× 227 0.4× 90 0.2× 207 5.0k
Wei Ge China 40 4.5k 1.0× 1.6k 0.6× 81 0.1× 627 1.0× 381 0.8× 169 7.5k
Quan Du China 36 3.1k 0.7× 857 0.3× 60 0.1× 162 0.3× 149 0.3× 134 4.4k
Natasha J. Caplen United States 40 6.9k 1.5× 3.4k 1.4× 156 0.2× 861 1.4× 942 1.9× 99 8.6k

Countries citing papers authored by Zhixiang Zuo

Since Specialization
Citations

This map shows the geographic impact of Zhixiang Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixiang Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixiang Zuo more than expected).

Fields of papers citing papers by Zhixiang Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixiang Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixiang Zuo. The network helps show where Zhixiang Zuo may publish in the future.

Co-authorship network of co-authors of Zhixiang Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixiang Zuo. A scholar is included among the top collaborators of Zhixiang Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixiang Zuo. Zhixiang Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yongqiang, Kai Yu, Jin‐Fei Lin, et al.. (2025). Deep learning prioritizes cancer mutations that alter protein nucleocytoplasmic shuttling to drive tumorigenesis. Nature Communications. 16(1). 2511–2511. 1 indexed citations
2.
Zhang, Luowanyue, Huiqin Li, Wei Liu, et al.. (2025). RMPore: a comprehensive database of single-molecule RNA modifications detected by Nanopore direct RNA sequencing. Nucleic Acids Research. 54(D1). D291–D302. 1 indexed citations
3.
Zhang, Luowanyue, Weiping Mu, Huiqin Li, et al.. (2024). RMVar 2.0: an updated database of functional variants in RNA modifications. Nucleic Acids Research. 53(D1). D275–D283. 4 indexed citations
4.
Jiao, Xingyuan, et al.. (2024). Targeting the PDE3B-cAMP-autophagy axis prevents liver injury in long-term supercooling liver preservation. Science Translational Medicine. 16(775). eadk0636–eadk0636. 2 indexed citations
5.
Li, Rui, Xuefei Liu, Xudong Huang, et al.. (2023). Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. Gut. 73(3). 470–484. 45 indexed citations
6.
Chen, Yan‐Xing, Zixian Wang, Ying Jin, et al.. (2023). An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma. Cancer Cell. 41(5). 919–932.e5. 22 indexed citations
7.
Liang, Jiaqi, Yubin Xie, Yanru Zeng, et al.. (2023). VSOLassoBag: a variable-selection oriented LASSO bagging algorithm for biomarker discovery in omic-based translational research. Journal of genetics and genomics. 50(3). 151–162. 15 indexed citations
8.
Zhang, Di, Huiqin Li, Xuefei Liu, et al.. (2022). TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource. Genomics Proteomics & Bioinformatics. 21(2). 337–348. 73 indexed citations
9.
Sui, Qiaoqi, Dingxin Liu, Jiang Wu, et al.. (2021). Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001498–e001498. 43 indexed citations
10.
Liu, Zekun, Qi Zhao, Zhixiang Zuo, et al.. (2020). Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer. iScience. 23(7). 101302–101302. 163 indexed citations
11.
Liu, Zekun, Kai Yu, Jian Zheng, et al.. (2019). Dysregulation, functional implications, and prognostic ability of the circadian clock across cancers. Cancer Medicine. 8(4). 1710–1720. 20 indexed citations
12.
Zheng, Yueyuan, et al.. (2019). lnCAR: A Comprehensive Resource for lncRNAs from Cancer Arrays. Cancer Research. 79(8). 2076–2083. 51 indexed citations
13.
Han, Yujing, Jing Feng, Linjian Xia, et al.. (2019). CVm6A: A Visualization and Exploration Database for m6As in Cell Lines. Cells. 8(2). 168–168. 40 indexed citations
14.
Xie, Yubin, Xiaotong Luo, Wenbin Ma, et al.. (2018). DeepNitro: Prediction of Protein Nitration and Nitrosylation Sites by Deep Learning. Genomics Proteomics & Bioinformatics. 16(4). 294–306. 78 indexed citations
15.
Miao, Yanyan, Mengni Liu, Yanru Zeng, et al.. (2018). Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development. Frontiers in Genetics. 9. 254–254. 24 indexed citations
16.
Li, Ting, Peishan Hu, Zhixiang Zuo, & Huai‐Qiang Ju. (2018). IDDF2018-ABS-0233 N6-adenosine methyltransferase METTL3 promotes tumour metastasis via SOX2 MRNA M6A modification in colorectal carcinoma. A17.1–A17. 1 indexed citations
17.
Hou, Panpan, Chao Wu, Yuchen Wang, et al.. (2017). A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. Cancer Research. 77(16). 4402–4413. 68 indexed citations
18.
Li, Zejuan, Ping Chen, Rui Su, et al.. (2016). PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL -Rearranged Disease. Cancer Research. 76(3). 619–629. 48 indexed citations
19.
Saloura, Vassiliki, Hyun‐Soo Cho, Kazuma Kiyotani, et al.. (2014). WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck. Molecular Cancer Research. 13(2). 293–304. 83 indexed citations
20.
Brägelmann, Johannes, Ibiayi Dagogo‐Jack, Mohamed El Dinali, et al.. (2013). Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49(6). 525–533. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026